Correlation Between ZyVersa Therapeutics and Regen BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Regen BioPharma, you can compare the effects of market volatilities on ZyVersa Therapeutics and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Regen BioPharma.

Diversification Opportunities for ZyVersa Therapeutics and Regen BioPharma

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between ZyVersa and Regen is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Regen BioPharma go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and Regen BioPharma

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to generate 0.8 times more return on investment than Regen BioPharma. However, ZyVersa Therapeutics is 1.25 times less risky than Regen BioPharma. It trades about -0.15 of its potential returns per unit of risk. Regen BioPharma is currently generating about -0.28 per unit of risk. If you would invest  201.00  in ZyVersa Therapeutics on August 31, 2024 and sell it today you would lose (94.00) from holding ZyVersa Therapeutics or give up 46.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

ZyVersa Therapeutics  vs.  Regen BioPharma

 Performance 
       Timeline  
ZyVersa Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Regen BioPharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

ZyVersa Therapeutics and Regen BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ZyVersa Therapeutics and Regen BioPharma

The main advantage of trading using opposite ZyVersa Therapeutics and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.
The idea behind ZyVersa Therapeutics and Regen BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges